Price Watch

What changed at ClearlyMeds

This public changelog records real provider-price checks, coverage changes, new medication milestones, and editorial updates. Dates change only when the underlying page or facts change.

Subscribe by RSS View the price index

July 18, 2026

Five current GLP-1 questions added

ClearlyMeds added dated answers covering Foundayo availability, retatrutide status, the Medicare GLP-1 Bridge, microdosing evidence, and 2026 compounding rules.

• Added FDA and CMS source links directly to current-event answers.
• Added exact publication and modification dates to each new question page.
• Added extractable answers, key facts, comparison tables, and matched FAQ schema.

Orforglipron availability and price Retatrutide approval status Medicare GLP-1 coverage GLP-1 microdosing evidence Compounded semaglutide legality

July 18, 2026

GLP-1 Telehealth Price Index launched

ClearlyMeds published a transparent comparison of starting prices and support models across 15 telehealth providers.

• Published the underlying provider table and methodology limitations.
• Marked provider prices with their actual April 6, 2026 verification date.
• Added Dataset structured data so search and answer engines can identify the original research.

View the GLP-1 Telehealth Price Index Read the scoring methodology